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Summary.-Mononuclear leucocytes were separated by Hypaque-Ficoll from 60
unselected primary colorectal carcinomas, and then fractionated by rosetting with
sheep erythrocytes, either alone (E) or coated with antibody and complement (EAC).
The E-rosetting cells, putative T lymphocytes, were cytotoxic in vitro to autologous
tumour cells in 18 of the 60 cases, whilst the EAC-rosetting cells were unreactive.
This intrinsic T-lymphocyte anti-tumour immunoreactivity was significantly asso-
Ciated with the presence of "cuffs" of small dark lymphocytes at the mesocolic or
pararectal edge of the primary tumours, but there was no correlation with anti-
tumour cytotoxic lymphocytes in the patient's blood at the time ofoperation.
INTRINSIC (stromal) lymphoreticular-
cell infiltration of many different types of
malignant tumours has generally been
shown to be correlated with a favourable
prognosis (Underwood, 1974). It is thus
reasonable to suggest that the infiltrating
lymphoreticular cells might have cyto-
clastic activity against the tumour cells,
thereby exerting some control over the
rate ofneoplastic growth and spread. Our
early attempts to test for in vitro anti-
tumour cytotoxicity of these cells, from
colonic carcinomas and melanonias, by
altering the ratio of lymphocytes to
tumour cells and culturing the resulting
suspensions, failed to reveal any evidence
of cytoclastic activity (Nind et aL, 1973).
This led us to conclude that theinfiltrating
lymphoreticular cells had been rendered
anergic, possibly by an excess of free
tumour antigen or by antigen-antibody
complexes (Nairn, 1976).
We have pui-sued the subject further in
colonic carcinoma, with modern separa-
tion techniques to exclude as far as
possible tumour cells and antigens from
the immunocyte preparations. This neces-
sitated separation and fractionation ofthe
mononuclear leucocytes. None of the
tumours in the study provided enough
cells for more than 2 fractions (E- and
EAC-rosette-enriched cells); the present
study is limited to examination of the
immunoreactivity of those 2 fractions.
We have separated, by Hypaque-Ficoll,
E- and EAC-rosetting cells from the crude
tumour-cell suspensions, and reactivity
by these fractions against cultures of
autologous tumour were tested in a
microplate system.
In 18 of the 60 cases studied, the E-
rosetting cells (i.e. T lymphocytes (Jondal
et al., 1972)) were cytotoxic to tumour
cells in vitro, whilst the EAC-rosettino,
cells were always unreactive. Positive
anti-tumour cytotoxicity by these in-
trinsic lymphocytes from within the
tumour mass was associated with the
immunomorphological tumour feature of
"cuffs" of small lymphocytes around the
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bloo(I vessels tiear the tLiniotii- edge,
suggesting possible emigratioii oflympho-
cytes from the bloodstream to the neo-
plasm. However, we were rarely able t,o
demonstrate in vitro, cytotoxic lympho-
cvtes in the blood of patients with cyto-
toxic intrinsic lymphocytes in theii-
tumour. Fifteen of 44 cases tested for
blood lymphocyte anti-tumour cyto-
toxicity at the time of operation were
positive, but only one case showed anti-
tumour cytotoxicity by both blood
lymphocytes and intrinsic tumotir E-
rosettinglymphocytes.
MATERIALS ANI) METHODS
Patient8 and specinten,..-The 60 patiei-its
Nvere severally operated on in 1975 and 1976
by 3 surgeons. All the patients had adeno-
carcinoma of the large bowel the age range
was 35-86 (mean 61) years. and 28 Nvere male.
The specimens Avere selected only in so far as
they were received unfixed within 24 h of
operation, andyieldedenough tissue topermit
itt, vitroimmunologicaltesting oftheseparated
lymphocytes against the primary tumour.
"Intrin,sic" lymphocyte preparatioit.-Sus-
pen.sions of tumour cells, NA-ere prepared by
mechanicalseparation as describedpreviouslv
(Nairn et al., 1971 Nind et al.. 1973). Tumoui-
tissue, usually 5-10 g, Nvas treased gently in
Medium 199 containing20% foetal calf serum
(hereafter referred to as, "Mediuin"'). The
crude cell mixture Nvas passed through nylon
wool under pressure to obtain a single-cell
suspension, -washed tNN-ice in Medium and
lavered on toHypaque-Ficoll(340/' Hvpaque,
IN"inthrop-, 9% Ficoll, Pharmacia. 5:12) and
centrifuged at 250 q maximum for 25 min.
The interft-tce layer of cells was removed and
adherent cells AN-ere depleted by incubation
A%-ith lymphocyte separation reagent (Tech-
nicon InstrumentsCorp., Tarrytown, N.Y.).
In the casesreported here (60 of80 attemp-
ted), the lymphocyte yield allowed E- and
EAC-rosette fractionation. The relative yield
oflymphocytes was dependent on the tuinour
size and more importantly on the degree of
stromal leucocytosis as seen from histological
examination of the tumours. Usually 106-107
cells were obtained before rosette purifica-
tion. This cell population coti-iprised 28-80%
E-rosetting cells, 7-53% EAC-rosetting cells
and 3-510// tumour cells. The cell suspension
NN-as also known to coiitaiii Fe receptor-
bearing cells (29-77%) as deteriiiined by
cytolysis ofantibody-coated chicken erythro-
cytes. This suspension (5 x 106 cells/ml) was
then divided into tNA-o equal parts: one was
rosetted with an equal volume of 5% sheep
erythrocytes (E), incubated at 37'C for 10
inin, centrifuged at 250 g for 5 initi and left at
0-4'C overnight in Medium -, tiie other was
incubated with sheep erytlirocytes coated
with haemolysin (C.S.L., Melboui-ne) and
mouse complement (EAC) for I 1-i at 37'C
(Matthews et al., 1976). The i-espective E-
and EAC-rosetted cells -were fractionated by
centrifugation on Hypaque-Ficoll at 250 y
for 25 min. The erythrocytes in the rosetted
pellets were lysed by addition of 10 vol. of
isotonic NH4Cl for 10 min and the remaining
cells (lymphocytes) AA-ere washed and left in
Medium until used.
After rosette sepai-ation, the respective
population of cells AAas enriched for either
"T lymphocytes" (88+6% E-rosettes, mean
+s.d.) or compleinent-bearino, "B cells"
(85+9% EAC-rosettes). Other than T or B
lymphocytes, the most pi-evalent cell type
in the final preparations was also lyinphoid
in appearance. A low percentage (<2%) of
eosinophils, macrophages and tumour cells
(usuallydead) variablycomprised the balance
of the cell types. In cases where tuinour-cell
contamination -was higher, rosette fractiona-
tion was repeated. In all cases studied, the
respectivenon-E-and non-EAC-rosetted inter-
face layer of cells consisted of contaminating
tumour cells. and thesepopulationswere never
used in microcytotoxicity assays.
Blood mononuclear cells were also ob-
tained by Hypaque-Ficoll fractionation froni
44 of the patients and. as controls. from 20
healthy laboratory NVorkers (age range 20-
25 vears). Twenty ml of heparinized blood
was mixed AN-ith an equal volume of O-Olm
phosphate-buffered saline (pH 7-2; PBS)
layered on to Hypaque-Ficoll, centrifuged
for 25 min at 250 g, and the interface layer of
cells was removed and washed x 6 in Medium.
In this AA,av the control lymphocytes were
washed to ihe same extent as test lympho-
cytes, to maintain comparability.
Hardly any natural killing (NK) of colonic
tuinour cells ANas seen with lymphocytes from
the panel of healthy donors (Appendix 1)
possi'bly because the target cells were short-
terin primarv cultures. Consequently, the
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enabled comparison of cytotoxicity levels
from patient to patient.
Lymphocyte cytotoxicity testiizg.-These
tests were performed on primary tumour-cell
microplate cultures by methods described
elsewhere (Nind et al., 1975). Crude tumour-
cell suspensions, adjusted to 105 cells/ml in
Medium, were micropipetted in 10 tzl
volumes into each well of a Falcon 3034
microculture plate, incubated for 24 h at
37'C in a moist atmosphere of 5% C02 in
air and then washed x 3 with Medium to
remove non-adherent tumour cells. Those
remaining in each ii-ell were counted. Test
and control lymphocyte preparations were
added to rows of 6 replicate wells for each
experiment to give a final effector: tumour
cell ratio of 100:1. For blood lymphocyte
cytotoxicity testing the effector: target cell
ratio Avas 200:1. The culture plate AA,as re-
incubated for a further 48 h, washed gently
x 3 with isotonic saline at 37'C and the re-
maining adherent cells NA-ere fixed with
methanol for 10 min and counted "blind"
underwater, using an invertedphase-contrast
microscope. Test lymphocyte preparations
were always accompanied by a row of homo-
logous control blood lymphocytes obtained
from I of 20 normal healthy adults of either
sex. Cvtoxicity was expressed as
nc-nT100
nc
where nc is the mean number of tumour cells
remaining adherent in the control wells and
nT the mean number remaining in the test
wells. Student's t test was performed for each
experiment and a difference bet,",een cyto-
toxicity means at the P <0-05 level was
regarded as significant.
Effect of rosette fractionation on lymphocyte
function.-Control experiments were per-
formed to establish whether or not the E-
rosetting technique would alter lymphocyte
in vitro immunoreactivity per se, because the
contamination of lymphocytes with tumour
cells did not permit parallel testing or un-
fractionated cells.
Sheep erythrocyte (E) rosetting lympho-
cytes from 82 draining non-infiltrated lymph
nodes (25 cytotoxic) from patients with
carcinoma of the colon were separated and
reacted against primary cultures of autoch-
thonous colonic carcinoma cells by the tech-
niques described above. In the positive cases,
cytotoxicitv values for the E-rosetted cells
(28 + 27%) were similar to those for the un-
fractionated population (38 + 11%) (unpub-
lished). Non-eytotoxic cases were not in-
fluencedby fractionation. Furthermore, blood
lymphocytes froin 5 healthy donors -were
treated in the same NN-ay and reacted against 5
colorectal carcinomas. There were no sig-
nificant differences between effects ofrosetted
and non-rosetted lymphocytes (Appendix 1).
In another set of experiments, blood lym-
phocytes Nvere separated from 3 donors into
4 fractions of 106 cells in 3 ml Medium 199
NA-ith 10% normal human AB serum. E-roset-
ting, non-rosetting, reconstituted E. and non-
rosetting, and unfractionated lymphocyte
suspensions were tested for their response to
phytohaemagglutinin (PHA) by the method
of Matthews & Maclaurin (1973). PHA
(Wellcome, England) was added to triplicate
test cultures at a final dilution of 1/40.
Control cultures were incubated with PHA.
After 72h incubation (5% C02 at 37'C),
4 ttCi of 3H-thymidine (sp. act. 5 liCi/mmol;
Radiochemical Centre, Amersham) in 50 til
of PBS was added and the incubation was
continued for another 4 h. Harvesting and
scintillation counting were as described
by Matthews & MacLaurin (1973). These
experiments showed significantly reduced
uptake of [3H]-TdR both by E-rosetting
and non-rosetting lymphocytes. Ho-wever,
-%A-hen E-rosetting and non-rosetting lympho-
cyte fractions were reconstituted, [3H]-TdR
uptake -%N,as at the same level as for the un-
fractionated lymphocytes (Appendix 11).
Thus our control experiments showed that
E-rosetting neither increased nor reduced
lymphocyte immunoreactivity per se to
colonic-carcinoma cells in culture, nor altered
their ability to transform into blast cells in
response to PHA stimulation. Although a
reduction in counts was observed with each
fraction, maximal counts Ni-ere obtained on
reconstituting E-rosetting and non-rosetting
cells, suggesting that both fractions remained
functional.
We were unable in this study to examine
directly any possible effects on lymphocyte
function of EAC-rosetting. We have, how-
ever, shown in parallel studies that the pro-
cedure of EAC-rosetting does not non-
specifically activate or depress cytotoxicity
of lymphocytes isolated from draining re-
tional (normal) lymph nodes (unpublished).
Briefly, in the non-cytotoxic cases, cyto-
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(0+3%) and non-rosetted (0+5%) cells
were similar to those for the unfractionated
population (I+4%). Similarly, in the cyto-
toxic cases, cytotoxicity values for the non-
EAC-rosetted cells (39 +14%) were similar to
those for the unfractionated population
(30+I%). Furthermore, Boxel et al. (1973)
have shown, in an antibody-dependent lym-
phoid-cell-mediated system in the mouse,
that EAC-rosetting of lymphocytes does not
affect their immunoreactivity.
Histological and immunomorphological as-
sessment.-Both conventional and immuno-
histological techniques were used. All tumour
and lymphnode sections were examined by
Dr E. Pihl without prior knowledge of the
in vitro data. Tumours were staged according
to Dukes' classification (Dukes, 1960): out of
the total of 60 cases, Dukes' A, B and C
tumours numbered 6, 22 and 32 respectively.
Conventional histological haematoxylin and
eosin sections, not less than 2 from each case,
were assessed for the presence of "cuffs" of
small, darklymphocytes around blood vessels
at the deep tumour edge, i.e., in the muscle
layers and adjacent pericolic/subserosal fat
(Figs. 1, 2). Such perivascular lymphocyte
cuffing was assessed quantitatively in each
case by the use of an integrating micrometer-
disc (Zeiss, Oberkochen) equipped with a
25-point standardized square graticule, at
x4 objective magnification. A minimum of
200 points was counted in each case; where
this criterion was not fulfilled with the x 4
objective, the x 10 wasused.
The relative surface area is proportional to
the number ofpoints over the areas measured
(Chalkley, 1943; Weibel, 1963). This was
expressed as a percentage of the total area
counted at the tumour edge as described
above. A minimum of 5% of the total area
was required for perivascular cuffing to be
recorded positive (Pihl et al., 1977).
Eighteen of the tumour specimens showed
At
'%F
.4S
FIEG. l.-Well differentiated papillary adenocareinoma of the colon, Dukes' Class A (Case 75/063), showing conspicuous perivascular lymphocytic infiltration in the vascular plexus of the muscle layers and subserosal fat (arrows).
(x 6 Haematoxylin staining alone for black-and-white photomicrographs.) Fre.. 2.-Perivascular infiltration, mainly by small, dark lymphocytes surrounding a venule (V) at the mosenteric edge of a colonic carcinoma (Case 76/194). Only occasional lymphoreticular cells present round artery and arteriole (A). (x 300 Staining as in Fig. 1.)843 LYMPHOID CELLS IN COLORECTAL CARCINOMA
such perivascular cuffing and in 41 cases it
was gcnegative" (less than 5% of the total
area covered). Assessment was not possible
in one case, as available sections did not in-
clude thedeep tumouredge.
RESULTS
In vitro intrinsic-lymphocyte anti-tumour
cytotoxicity
E-rosetting "T lymphocytes" extracted
from 18/60 (30%) primary colorectal
carcinomas were cytotoxic to autologous
tumour cells. Results for the 18 positive
cases together with the blood-lymphocyte
cytotoxicity values and histopathological
data are recorded in Table 1. The EAC-
rosetting cells were never cytotoxic.
The proportions of E-rosetting cells
expressed as a percentage of the total
number of lymphoid cells (recorded in
Table II) were not significantly different
in cytotoxic (59 + 15) in comparison with
non-eytotoxic cases (54 +26). The pro-
portions of EAC-rosetting cells, however,
were higher in the cases with cytotoxic
T cells (35 + 18) than in the non-eytotoxic
cases (20 + 13; P <0-05).
TABLE I.-% Cytotoxicity ofintrinsic and bloodlymphocytes in relation tostromalperivas-
cular lymphocytic cuffing and tumour staging
Tumour features
r-
A
Perivascular
lymphocyte
Dukes' cuffing
stage Mt
A 8
B 9
B 9
B 17
A 13
c 6
B 7
B 17
A 12
B I
c 6
c 3
c 6
c 3
A 5
A I
B 2
c I
. not done
Intrinsic lymphocytes
A
I
E-
rosetted
fraction
45***
44***
41***
40**
39**
36**
34*
30***
30**
31*
31**
28**
27***
26***
23***
23***
22***
22***
EAC-
rosetted
fraction
12
0
4
0
3
6
9
10
3
5
0
2
1
0
2
0
2
1
Blood
lymphocytes
86***
0
17
2
0
8
0
18
2
...
...
0
10
0
...
Case No.
75/130
76/194
76/121
75/182
76/075
76/195
75/082
76/144
75/063
76/084
76/113
76/016
76/019
76/132
76/091
75/149
76/185
76/043
* p < 0-05 ** p < 0-01 *** p < 0-001
t 5% or more regarded as positive.
TABLE II.-Intrinsic lymphocyte subclasses in relation to anti-tumour cytotoxicity
Lymphocyte subclasses
in crude "tumour" cell
suspensions
(mean % ± s.d.)
A
r 'N
E- EAC-
rosetting rosetting
cells cells
59 + 15* 35 + 18**
54+ 26 20+ 13
Lymphocyte cytotoxicity
(mean +s.d.)
r. 'l-7
I
E- EAC-
rosetting rosetting
cells cells
32 + 8 3 + 4
2 + 3 2 + 2
Cases (No.)
Cytotoxic (18)
Non-eytotoxic (42)
* Not significantly different from corresponding non-cytotoxic cases.
** Significantly different fromcorrespondingnon-cytotoxic cases (P <0-05).844 J. A. WERKMEISTER ET AL.
extent of lymphocytic infiltration of the
tumours.
Lymphocytes from the tumour stroma
were fractionated by E- and EAC-
rosettino, techniques and tested for anti-
tumour cytotoxicity in microplates. The
reported "gelling" of colonic tumour cells
upon centrifugation on Hypaque-Ficoll
was not seen in this or previous studies in
our laboratores (Nind et al., 1973), prob-
ably because of our initial passage of the
tumour-cell suspension throuah nylon
wool. The reported reduction in lympho-
cyte cytotoxicity which follows treatment
with ammonium chloride (Potter & Moore,
1979) did not seem to influence our re-
sults, probably because the lymphocytes
were then kept in Atedium for more than
16 h. i.e. until the primary tumour-cell
cultures were established. In 60 cases of
primary colorectal carcinoma, significant
in vitro lymphocyte cytotoxicity against
autochthonous tumour cells was found in
18 cases (30%). The cytotoxic effector
cells were found only in the E-rosette-
enriched population of cells, i.e. putative
T-lympbocytes (Jondal et al., 1972).
The relative proportions of T lympho-
cytes (E-rosetting cells) were similar in
the cytotoxic and non-cytotoxic cases.
However, there were higher proportions
of EAC-rosette-forming cells in the cyto-
toxic cases. The biological significance of
this phenomenon is unknown. Indeed the
EAC-enriched population of intrinsic cells
was never cytotoxic. The results suggest
that stromal lymphocyte "anergy" is not
due to a relative T-lymphocyte decrease.
Whilst the relative proportions of intra-
tumoral T cells did not vary, absolute
values between cytotoxic and non-cyto-
toxic cases did vary, as shown by an
association between high stromal lympho-
reticular-cell infiltration and intrinsic T-
cell cytotoxicity.
The apparent discrepancy between our
previous findings of anergic intrinsic,
tumour lymphoreticular cells (Nind et al.,
1.973) and our present demonstration of
cytotoxicity is likely to be due to differ-
ences in technique. Previousiv we were
Intrinsic-cell anti-tuniour cytotoxicity in
relation to blood-lyniphocyte cytotoxicity
Ofthe cases with intrinsicT-lymphocyte
anti-tumour cytotoxicity, only one of 12
tested (75/130, Table 1) sliowed cyto-
toxicity by blood lymphocytes at the time
oftumo-tir resection. Ofthe 42 that did not,
show intrinsic-cell reactivity by E- or
EAC-rosetting fractions, the blood lym-
phocytes from 1.4 of 32 tested -were
positive.
In vitro cytotoxicity by intrinsic lyiiipho-
cytes in relatiort to tutiwurfeatures
Intrinsic-lymphocyte anti-tumour cyto-
toxicity and perivascular cuffing were
either both present or both absent in 47 11
cases (80% concordance) assessed for
cytotoxicity. This association was statis-
tically highly significant (P < 0-00I; Table
TABLE III.-Intrin8ic lymphocyte anti-
tunioui- cytotoxicity in relation to peri-
va,scular cu nq at the tumour edge
Perivascular
lympliocyte cuffing
(No. ofcases)
Intrinsic lympliocytes Present Absent
ytotox,IC 12 6
,Kol-l-cy-totoxic 6 35
x2
= 13-8 (P <0-001).
Twelve of the 18 tumours with cyto-
toxic E-rosetting lymphocytes and 6 of
the other 42 whose intrinsic lymphocytes
showed no reactivity were non-metastatic,
i.e. Dukes' Stages A & B (X2 = 3
-05;
0-05<P<0-1). This possibly favourable
association between intrinsic-lymphocyte
cytotoxicity and tumour metastasis was
not, statistically significant.
DISCUSSION
Investigation of stromal leucocytosis in
human colorectal carcinoma bas shown
thatimmunoreactivity ofintrinsic stromal
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unable to separate the viable lympho-
reticular cells from contaminating tumour
cells. The results reported here indicate
the presence ofcytotoxic T cells within the
stroma of progressively growing human
colorectal adenocareinomas. It is well
recognized that soluble tumour antigen
in vivo could bind to the surface ofeffector
cells and prevent their interaction with
tumour cells. Such effector-cell anergy
might account for the disparity observed
between in vitro tumourkilling and in vivo
tumourprogression.
In the present work, tumour-cell con-
tamination ofpurified T- and B-cell popu-
lations was less than 2%. Moreover, the
extensive washing of effector cells (6
times), which has been reported to in-
crease both lymphocyte cytotoxicity
(Currie & Basham, 1972) and PHA-
inducedlymphocyte transformation (Man-
nick et al., 1977) in cancerpatients, should
reduce binding of soluble tumour antigen
or antigen-antibodycomplexes to effector
cells (Nind et al., 1975). For all tests, the
same extensive -washing (6 times) of
normal control peripheral-blood lympho-
cytes permitted comparative assessment
of test and control lymphocyte cyto-
toxicities. Our experiments also showed
that the procedures of E- and EAC-
rosetting gave no nonspecific augmenta-
tion or suppression of the reactivities
tested on the purified cell populations.
The microcytotoxici-ty assay used in
these studies has been shown here and
previously (Nind et al., 1975) to monitor
lymphocyte cytotoxicity, not cytostasis.
The very low levels ofNK activity of con-
trol lymphocytes against colonic target
cells allowed direct comparisonsofspecific
cytotoxicity between patients. Possible
explanations of the apparent low NK level
include low NK activity of donor effector
cells and lack of NK recognition of
antigen on colonic-cell primary cultures.
Our present findings are in agreement
with the work of others on Burkitt's
lymphoma (Jondal et al., 1975) and on
lung and nasopharyngeal tumours (Vose
et al., 1977), in which a similar incidence
57
of intratumoral lymphocyte cytotoxicity
wasreported.
No direct association was found be-
tween intrinsic and blood lymphocyte
anti-tumour cytotoxicity; of the 15 cases
withblood-lymphocyte cytotoxicity at the
time of operation, only one showed
intrinsic stromal E-rosetting-lymphocyte
cytotoxicity. Analysis of our data shows
in vitro cytotoxicity by intrinsic E-
rosetting lymphocytes in 5/6 (83%)
Dukes' A, 7/22 (32%) Dukes' B and 6/32
(19%) Dukes' C cases. The correlation
between intrinsic stromal lymphocyte
cytotoxicity and tumour metastasis was
only marginal, i.e. cytotoxicity may re-
flect local anti-tumour reactivity against
invasive growth. On the other hand,
peripheral-blood lymphocyte cytotoxicity
was seen in 0/6 (0%) Dukes'A, 5/22 (23%)
Dukes' B and 9/32 (28%) Dukes' C cases.
Thus, whilst migration of specifically
cytotoxic E-rosetting lymphocytes from
the bloodstream to the tumour may occur
eventually, it may equally be true that
stromal intrinsic immunoreactivity is a
relatively early event in tumour develop-
ment. It could theoretically result from
initial infiltration and cellular trapping of
unprimed nonspecific inflammatory cells,
possibly with specific cytotoxic T cells
from the blood accompanied by intrinsic
lymphocyte activation and proliferation.
The correlation ofintrinsic (i.e. stromal)
E-rosetting lymphocyte anti-tumour re-
activity with the presence ofperivascular
cuffing by lymphocytes suggests that
immunoreactive cells may first become
localized mainly at the tumour edge,
although these perivascular cells have not
yet been characterized immunologically.
It may also be relevant that the presence
ofsuchperivascular cuffs ofsmalllympho-
cytes is associated with prolonged re-
currence-free survival inStage B colorectal
carcinoma (Pihl et al., 1977). Conse-
quently both intrinsicE-rosettinglympho-
cyte cytotoxicity and stromalperivascular
cuffing may reasonably be assumed to
reflect beneficial local immunocyte anti-
tumourimmunoreactivity.846 J. A. WERKMEISTER ET AL.
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APPENDIx I.-Effect of E-rosetting frac- "O
tionation on in vitro natural non-specific
lymphocytereactivity against tumour cells
Mean tumour
Lymphocyte cells per well
Exp. fraction +s.d.
I E-rosetted 20-5 + 3-7
Non E-rosetting 22-3+5-7
Unfractionated 21-3+4-1
No lymphocytes 22-9 + 4-6
2 E-rosetted 16-7+ 6-7
Non E-rosetting 15-2+4-6
Unfractionated 17-3+ 5-7
No lymphocytes 18-0+ 3-1
3 E-rosetted 28-0+5-0
Non E-rosetting 25-8+ 6-0
Unfractionated 27-2 + 3-6
No lymphocytes 28-1+ 6-2
4 E-rosetted 34.8+5.8
Non E-rosetting 35-7+ 7-0
Unfractionated 36-8 + 2-9
No lymphocytes 33-2 + 4-9
5 E-rosetted 32-8 +4-7
Non E-rosetting 36-2+ 8-5
Unfractionated 33-2 + 4-0
No lymphocytes 30-9 + 4-0
Effector:target cellratio, I00:1.
A-PPENDIX II.-E ct of E-rosette frac- Iffe
tionation onphytohaemagglutinin (PHA)
stimulation of normal lymphocytes
3H-thymidine uptake
(ct/min x 10-3)
Lymphocyte Without With
Exp. fraction PHA PHA
1 Unfractionated 1-6 135-5
E-rosetted 0-8 49-0**
NonE-rosetting 2-4 5-7***
E and non-E 1.5 122-5
re-constituted
2 Unfractionated 1.1 83-5
E-rosetted 0-9 25-6**
NonE-rosetting 2-2* 5.0***
E and non-E 1-2 78-6
re-constituted
3 Unfractionated 1.0 68-5
E-rosetted 1.0 21-4**
E and non-E 2-0 59-6
re-constituted
Significance of difference from unfractionated
cells: *.P <0.05; ** P <0.01; *** P < 0-ool.
APPENDIX III.-Protocol of intrinsic
lyniphocytecytotoxicitytesting
Mean no.
tumour
cells % Cyto-
+s.d. toxicity
Patient A. (54% E, 40% EAC)
Blank 30-8+5-1
Normallymphocytes 27-5 + 6-6
E-rosetted intrinsic
lymphocytes 16-7+ 2-7 39-4
EAC-rosetted intrinsic
lymphocytes 28-3 + 7-7
Patient B. (70% E, 15% EAC)
Blank 38-5+ 4-4
Normallymphocytes 36-8 + 2-9
E-rosetted intrinsic
lymphocytes 35-7 + 5-9 3-2
EAC-rosetted intrinsic
lymphocytes 36-1+ 8-5 1-8
Patient C. (48% E, 32%EAC)
Blank 39-5+ 3.4
Normallymphocytes 40-0+1-3
E-rosetted intrinsic
lymphocytes 23-7 + 2-8 40-8
EAC-rosetted intrinsic
lymphocytes 41-8+ 6-4 -4-6
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